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During differentiation in a thymus, T  lymphocytes learn to recognize self alloanti- 
gens determined by the H-2 major histocompatibility complex. This imposes certain 
genetic  restrictions  on  lymphocyte interaction  during T  cell-mediated  immune  re- 
sponses (1-3). For example, antigen-specific helper T  cells acquire a binding capacity 
not only for a given foreign antigen but also for Ia alloantigens of the host haplotype. 
Our previous studies have shown that soluble allogeneie effect factors (AEF) a derived 
from  mixed  lymphocyte  reaction  (MLR)  cultures  of  graft-versus-host  reaction 
(GVHR)-activated responder T  cells and either H-2-  (4, 5),/-region- (6),/-subregion- 
(7,  8)  or  Mls-locus-  (9)  incompatible  irradiated  stimulator  cells  are  genetically  re- 
stricted in their helper activities. They each preferentially help primary and secondary 
antibody responses of B cells  of the stimulator haplotype. The activity of several of 
these factors may be absorbed by alloantibodies reactive with I-A-  (5, 6)  or I-J-  (8) 
subregion products of the stimulator haplotype but not of the responder haplotype. 
The genetic restriction of these responses may be controlled in part by the acquisition 
by GVHR donor and MLR responder cells  of GVHR host and MLR stimulator Ia 
antigens (10). Thus, although it is apparent that both helper T  cells and AEF helper 
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factors  recognize  an  immunogen  in  association  with  syngeneic  Ia  antigens,  the 
molecular basis for this associative recognition is unknown. It was therefore of interest 
to biochemically and biologically characterize the component(s) of an AEF that is H- 
2 restricted in its activity for a  B  cell response of the stimulator haplotype. 
In this report, we demonstrate that a genetically restricted AEF produced across an 
11-2  incompatibility consists  of two  main  active  components.  One  component,  of 
~30,000-35,000  mol wt, possesses identical biochemical and biological properties to 
murine  T  cell-growth  factor  (TCGF)  (11)  and  is  not  genetically  restricted  in  its 
activity. The other component  has a  mol wt  of ~68,000,  differs both  biochemically 
and biologically from TCGF, and is genetically restricted in its helper activity for B 
cells of the stimulator haplotype and of haplotypes that share/-A-region identity with 
the  stimulator  haplotype.  It  is  suggested  that  the  latter  AEF  component  is  an 
alloactivated responder T  cell-derived receptor for stimulator cell /-A-controlled Ia 
alloantigens. 
Materials and  Methods 
Mice.  Mice used in this study were either bred and maintained at the University of Toronto, 
Toronto, Canada or purchased from The Jackson Laboratory, Bar Harbor, Maine. 
Antigens.  Burro and sheep erythrocytes were purchased from Colorado Serum Co., Denver, 
Colo. 
Antisera.  The anti-H-2 and anti-Ia alloantisera and the rabbit anti-bovine serum albumin 
(BSA) serum used were produced at the University of Toronto. A303 is a monoclonal antibody 
that detects Ia antigens whose a-chain subunit (E,) is controlled by a gene in 1-E k and whose 
fl-chain subunit (A~) by a gene in 1-A k (12). Either a (B6.PL-Thy-I.1 ×  PL/J)F1 anti-C57BL/ 
6 congenic anti-Thy-1.2 serum or an anti-Thy-1.2 hybridoma antibody (13) was used to deplete 
suspensions of T  cells. Rabbit anti-mouse Fv and chicken anti-mouse Ig were kindly provided 
by Dr. M. Feldmann, Department of Zoology, University College, London, England. Rabbit 
anti-mouse VH, rabbit anti-mouse VL, and normal rabbit Ig were generously supplied by Dr. 
M.  Feldmann but  were  produced by Dr.  D.  Givol, Department  of Chemical  Immunology, 
Weizmann Institute of Science, Rehovot, Israel. A goat anti-Scripps virus gp 70 antiserum was 
kindly provided by Dr. S. Kennel, Oak Ridge National Laboratory, Oak Ridge, Tenn. A rabbit 
antiserum against the cross-reactive idiotype (CRI) of serum anti-p-azophenylarsonate antibod- 
ies  produced  in  A/J  mice  (14)  was  kindly supplied by  Dr.  J.  D.  Capra,  Department  of 
Microbiology, Southwestern University of Texas, Dallas, Tex. 
Preparation of AEF.  AEF was  produced across an  H-2  incompatibility by using GVHR- 
activated A.SW (H-2 ~) responder T cells and irradiated A/WySn (H-2 a) stimulator spleen cells, 
according to procedures previously described (4-9). Briefly, spleen cells were recovered from 
irradiated (800 rad) A/WySn recipients that were injected intravenously .5 d  earlier with  10  s 
A.SW thymocytes. Supernates were recovered from 16- to 20-h MLR cultures (1-ml volume) in 
a serum-free RPMI-1640 medium (8) of 107 A.SW activated responder spleen T  cells and  107 
irradiated (3,000 rad) normal stimulator A/WySn spleen lymphocytes. They were then assayed 
for AEF activity. 
Chromatographic Resolution of AEF.  All chromatography was performed at 4°C using sterile 
buffers, essentially as described before (11). 
Approximately 1.5 ml of unseparated AEF was applied to a 2- ×  90-cm column of UItrogel 
ACA  54  (Fisher  Scientific Co.,  Pittsburgh,  Pa.)  previously equilibrated  with  0.9%  NaCI. 
Column fractions (8 ml) were eluted in this buffer and their OD~0 were continuously monitored 
with an LKB Uvicord II (LKB Instruments, Inc., Rockville, Md.). The column was calibrated 
with  the  following molecular weight  standards:  human  serum  albumin  (mol  wt  67,000), 
ovalbumin (tool wt 43,000), TCGF (mol wt 30,000),  and cytochrome c (tool wt  12,500). 
Biologically active fractions (see  Fig. 2A, pools I  and  II)  from  the ACA 54  column  were 
dialyzed against 0.04 M  NaCI buffered in 0.01 M  Hepes, pH 7.2, and applied to a  1.5- X 8-cm 
column of DEAE-Sephacel (Pharmacia Fine Chemicals, Uppsala, Sweden)  previously equili- DELOVITCH  ET  AL.  109 
brated in this buffer. Column fractions (8 mi) were eluted using a  120-ml linear gradient of 
0.04-0.5 M NaCI buffered in 0.01 M  Hepes, pH 7.2, and their ionic strengths monitored with 
a conductivity meter. 
Active fractions that eluted between 0.05 and 0.1 M NaC1 (Fig. 3, pool III) from the DEAE- 
Sephacel column were dialyzed against 1% 81ycine, adjusted to contain 2% Ampholines (pH 3- 
10;  LKB Instruments, Inc., Rockville, Md)  and then mixed with 5 g of Uhrodex  (treated 
Sephadex G-75; LKB Instruments, Inc.). T ae gel suspension was spread on a horizontal flat- 
bed isoeleetric  focusing (IEF) tray and electtophoresis was carried out at 5°C for 26-30 h using 
a constant current of 8 mA (see Fig. 4A) (11). After IEF, gel sections were made, analyzed for 
their pH, and then transferred to  1- ×  5-cm columns that were eluted with 5-10 ml sterile 
water. Each sample was dialyzed against 0.04 M NaCI to remove Ampholines, lyophilized, and 
finally resuspended in 200 pl sterile water before assay. 
Alternatively, selected  DEAE column fractions were  further resolved  by IEF on a  110-ml 
preparative column (model 8100-1; LKB Instruments, Inc.) that was stabilized with a gradient 
of 0-60% glycerol  (15). Ampholytes (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) in 
the pH range of 3-10 were added to the gradient at a 1:40 dilution. Electrophoresis was carried 
out  for  25  h  at  4°(3.  40  2.5-ml  fractions were  collected,  their  pH  determined, and  then 
neutralized to pH 7.2 using 1 M Tris base before assay. 
Radioiodination of AEF.  Biologically active AEF fractions separated by IEF were dialyzed 
using sterilized Spectrapor membranes (3,500-mol  wt cutoff; Spectrapor Medical Industries, 
Los  Angeles, Calif.)  for 48 h  against phosphate-buffered saline (PBS),  pH  7.4, with several 
buffer changes. They were then concentrated with Millipore (Millipore Corp., Bedford,  Mass.) 
immersible CX uhrafihration units (10,000-mol wt cutoff), and adjusted to pH 8.5 using 1 M 
PBS, pH 9. Samples were labeled with 12sI using the Bolten-Hunter reagent (>1375 Ci/mmole 
sp act; Amersham Corp., Oakville, Ontario) according to the method of Langone et al.  (16), 
with the exception that a PBS buffer that contained 0.1% gelatin and 10 mM Tris-HCl, pH 
7.4, was used (12). 
Gel Electrophoresis of AEF.  125I-labeled  AEF fractions were  analyzed under reducing and 
nonreducing conditions by one-dimensional (l-D)  sodium dodecyl sulfate  (SDS)-polyacryl- 
amide (10% wt:vol) slab gel electrophoresis (SDS-PAGE) or were subjected to electrophoresis 
on  a  two-dimensional (2-D)  gel  according to  the  method  of O'Farrell  (17),  as  previously 
described (18). Dried gels were impregnated with EN3HANCE (New England Nuclear, Boston 
Mass.)  and were  then exposed  to  preflashed  (19) Kodak XR-1  film  (Eastman Kodak Co., 
Rochester, N. Y.) using a Cronex Lightning Plus image-intensifying  screen (Du Pont Canada 
Inc., Markham, Ontario, Canada). 
Immunoprecipitation ofofAEF.  Aliquots (50/tl) of x25I-labeled  AEF previously purified by IEF 
and containing ~5,000-6,000 cpm were reacted with 25 #1 of various antisera for  18 h at 4°C. 
Samples were  further treated for 30 min at  4°C with  100 p.1 of a  10%  (vol:vol)  heat-killed, 
formalin-fixed suspension of Staphylococcus aureus, Cowan  I  strain  (SaCI).  They  were  then 
centrifuged at 6,300 g for 15 rain through 1 ml of 2 M sucrose in 0.02 M Tris-HC1, pH 7.4, to 
remove unbound antibody and to dissociate  nonspecifically formed immune complexes.  After 
washing of the pellets three times with  1 ml of PBS that contained 0.5% Nonidet P-40 and 5 
mM KI, they were resuspended at 23°C in 50 p.l of a solution of 2% (vol:vol) 2-mercaptoethanol 
and 5% (vol:vol)  SDS, centrifuged, and the radioactivity in the supernates was determined in 
a Beckman 300 gamma counter (Beckman Instruments, Inc., Fullerton, Calif.). 
Biological Assays ofAEF. AEF fractions separated by ACA 54, DEAE-Sephacel and IEF were 
assayed for their capacity to promote (a) the proliferation of mouse cytotoxic T  lymphocytes 
(CTC) harvested from long-term TCGF-dependent cultures (CTLL cells), (b) concanavalin A 
(Con A)-induced mitogenesis  of normal mouse thymocytes, (c) cytolytic reactivity to alloantigens 
in mouse thymocyte and nude spleen cell cultures, and (d) antibody responses  to either sheep 
or burro erythrocytes (SRBC, BRBC) in cultures of either nude mouse spleen or T cell-depleted 
normal spleen cells. These assays were performed as previously reported (8, 9,  11). After each 
biochemical method of resolution of AEF, aliquots of isolated fractions were examined for 
activity in each of the above biological tests. Fractions were assayed in replicate at concentrations 
ranging between 5 and 50%  (vol:vol).  Peak responses  in thymocyte mitogenesis, CTL, and 
antibody production assays were usually observed at a sample concentration of ~5-10%. 1 10  TWO  COMPONENTS  OF  ALLOGENEIC  EFFECT  FACTOR 
Results 
H-2-restricted Helper Activity of Unfractionated AEF.  Table I summarizes our previous 
studies in which 9 out of 10 AEF generated across either H-2 ([4, 5]; and T. Delovitch. 
Unpublished  observations.),/-region  (6),/-subregion  (7,  8), or Mls-locus  (9)  incom- 
patibility  displayed  an  H-2  restriction  in  their  helper  activity  for  B  cells  of the 
stimulator haplotype. An AEF (AEF-1) generated using B I0.BR activated responder 
T  cells and B10.S irradiated stimulator spleen cells was the only AEF that elicited an 
equivalent response of B cells of the responder and stimulator haplotypes (4). However, 
it  showed  an  apparent  genetic  restriction  as  it  helped  B  cells  of only some of the 
haplotypes tested. The difference in activity of this AEF when compared with that of 
the nine others listed in Table I may be because:  (a) it was produced in the absence 
of the antiserum  plus complement  (C')  treatments of the responder and stimulator 
cells  used  for AEF-2  (5)  and  (b)  it  was  produced  using an  x-ray source and  tissue 
culture  medium  that  differed  from  those  used  to  generate  AEF  3-10  (4-9).  The 
conditions used for the latter AEF were those indicated  for AEF-4 in the Materials 
and Methods section of this report. Because genetic restriction of helper activity was 
displayed  for all  AEF  examined  and  in  90%  of the  cases  AEF  helper  activity was 
restricted  to  cells  of  the  stimulator  haplotype,  it  was  conceivable  that  a  major 
component, which mediated this type of H-2 restriction, was present in each of these 
AEF. 
Thus,  a  biochemical and  biological analysis of an  AEF  produced  across an H-2 
incompatibility was performed. Because an AEF generated across an H-2 difference 
yields the strongest helper activity (Table I) and the H-2 ~ and H-2 k haplotypes differ 
most widely in  their expression of Ia antigenic  specificities, AEF was derived  from 
MLR cultures of A.SW (H-2 ~) GVHR-activated responder T  cells and A/WySn (H- 
2 a)  irradiated  stimulator  spleen  cells.  These  strains  were  in  greater supply  in  our 
TABLE  I 
Helper Activities of Various AEF 
Strain*  Activity§ 
Responder 
Incompatibil-  H-2 restric- 
Stimulator  ity:~  Re-  Stimula-  tion 
sponder  tor 
1.  B10.BR  BI0.S  H-2 s  ++++  ++++  No 
2.  B10.BR (Ia-)  B10.S (Thy-  H-2"  ±  ++++  Yes 
1.20) 
3.  B10.S  B 10.BR  H-2 k  ±  ++++  Yes 
4.  A.SW  A/WySn  H-2 ~  +  ++++  Yes 
5.  A.TH  A.TL  I~,TL?,Qa?  +  ++++  Yes 
6.  (A.TH ×  B10.HTT)F~  A.TL  1-Ak,I-B~,I-J k  :t:  +++  Yes 
7.  B 10.A(3R)  B 10.A(5R)  l-J k  -  ++  Yes 
8.  B 10.A(5R)  B 10.A(3R)  l-J b  -  ++  Yes 
9.  B 10.S(7R)  B 10.HTT  I-ECk, TL?,Qa?  ±  +++  Yes 
10.  C3H/HeJ  B 10.BR  Mls b  -  ++  Yes 
* Strains used for the production of AEF. 
:[: Genetic incompatibility in the GVHR and MLR phases of AEF production. 
§ Helper activity with T-cell depleted spleen cells of either responder or stimulator haplotype.  Relative 
strengths of AEF helper activity are shown as: ++++  (2,000-3,000  PFC/107 cells), +++  (1,000-2,000 
PFC/107 cells), ++  (300-1,000  PFC/107 cells), +  (100-300  PFC/107 cells), ±  (50-100 PFC/107 cells), 
and -  (<50 PFC/107 cells). DELOVITCH  ET AL.  111 
colony than  the histoeompatible B I0.S(H-2 s)  and  B10.BR(H-2 k)  strains previously 
used for AEF 1-3. They also enabled the use of several recombinants of the H-28 and 
H-2 k haplotypes to carry out genetic mapping studies of AEF helper activity. 
Fig.  1A demonstrates  that  AEF preferentially helps A/WySn,  but  not  A.SW, T 
cell-depleted spleen cells. Optimum  helper activity was obtained at a  concentration 
of 0.01%  (i.e., a  dilution  of 1:10,000).  AEF helper activity is, therefore,  genetically 
restricted for B cells of the stimulator haplotype. This AEF also helps B 10.A, B 10.BR, 
B10.S(SR),  B10.A(4R),  A.TL,  and  BALB/c  B  cells;  but  not  A.TH,  B10.S,  B10, 
BI0.A(5R),  and  BI0.HTT  B  cells  (data  not  shown).  Thus,  AEF  seems  to  help 
primarily B cells of haplotypes that share/-Ak-subregion identity with the stimulator 
haplotype. The only exception to this I-A identity requirement for AEF activity is the 
BALB/c strain; the reason that AEF helps this strain is presently not understood and 
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Fro.  1.  H-2 restriction and immunoadsorption  of AEF helper activity. (A) Anti-Thy-1.2 plus C'- 
treated spleen cells (106) from either responder  (R)  A.SW  (0)  or stimulator (S) A/WySn (A) 
unprimed  mice were cultured with or without BRBC (3 X 10  s) in the absence or presence of AEF 
at various final concentrations  ranging from 0.0001 to 10% (vohvol). Direct PFC in triplicate 5-d 
cultures in RPMt-1640 medium containing 5% fetal calf serum were enumerated  and are presented 
as SEM (arithmetic). The results of two experiments are shown. Background PFC values obtained 
in the absence of antigen ranged from 0 to 100 and have been subtracted. T~ae haplotype origin of 
the H-2 regions of the strains used are indicated.  (B) Anti-Thy-l.2 plus C'-treated A/WySn spleen 
cells were cultured with or without  antibody-column  adsorbed  AEF. The anti-Ia sera used for 
adsorption and their potential reactivities are presented. Other conditions used are as in (A) above. 112  TWO COMPONENTS OF ALLOGENEIC EFFECT FACTOR 
may be related to a  structural  homology of Ia  k and  la  d antigens  (see  Discussion). 
Compatible with this mapping data is the finding that AEF helper activity for A/ 
WySn  T  cell-depleted  spleen  cells  could  be  removed  by  immunoadsorption  on 
cyanogen bromide-activated  Sepharose 4B  columns  conjugated with  either A.TH 
anti-A.TL (anti-I~,S  k) or (A.TH ×  B 10.HTT)F1 anti-A.TL (anti-l-A k,l-B*,I-Jk), but 
not with (B 10 ×  HTI)F1 anti-B10.A(5R) (anti-I-Jk,I-Ek,I-CY,S  a) or A.TL anti-A.TH 
(anti-Ia,S  8) (Fig. 1B). These observations suggested that unfractionated AEF possesses 
a  component(s), potentially responder T  cell membrane-derived, that can recognize 
and bind to Ia antigens determined by the I-A h subregion of the stimulator haplotype. 
To attempt to understand the molecular basis of T  cell recognition of Ia alloantigens, 
it  was  considered  important  to  identify such  an  AEF  component.  A  biochemical 
characterization of AEF  was,  therefore, performed.  AEF  was  subjected  to  various 
methods of resolution and the fractions obtained examined for their activity in several 
biological assays. 
Gel Filtration.  Approximately 15 ml of AEF harvested in a serum-free RPMI-1640 
medium  supplemented  with  the  protease  inhibitor  Trasylol  (8)  was  fractionated 
according to size by chromatography in  0.9%  NaCI  on  an  ACA  54  column.  The 
fractions obtained were  assayed  at  a  1:10  dilution  for their ability  to stimulate  a 
primary in vitro anti-SRBC direct plaque-forming cell (PFC) response of either nude 
spleen cells or T  cell-depleted spleen cells under culture conditions that were limiting 
for helper T  cells (11).  Fig. 2A shows that fractions eluting in the 50,000- to 70,000- 
and 25,000- to 35,000-mol wt ranges, designated pools I and II, respectively, potentiate 
a PFC response of BALB/c (H-2 a) nude spleen cells. The helper activity, expressed as 
the  fraction of responding microcultures, of pool I  was about twofold greater than 
that of pool II. This AEF helper activity for BALB/c nude spleen cells is consistent 
with the observation of AEF helper activity for BALB/c T  cell-depleted spleen cells 
mentioned above.  Pool II  displays TCGF-like activity when  tested  (fractions were 
diluted  1:5) for their capacity to stimulate  the growth of TCGF-dependent CTLL 
cells  (Fig.  2A),  and  promotes  Con  A-induced  mitogenesis  of thymocytes and  the 
generation of cytotoxic T  cells in either thymocyte or nude spleen cell cultures  (J. 
Watson.  Unpublished observations.). By contrast, pool I  does not possess  any of the 
latter three biological activities. Pool I also differs from pool II because it helps a PFC 
response of B10.A but  not  B10.S T  cell-depleted spleen cells  (Fig.  2B).  Again,  the 
helper activity of pool I was about twice that of pool II. This indicates that the helper 
activity of pool I is restricted to B cells that are histocompatible with the stimulator 
haplotype  and  not  the  responder haplotype;  the  helper  activity of pool  II  is  not 
genetically restricted. Thus, gel filtration demonstrates that AEF may be resolved into 
two main components, pool I  and pool II, which differ in their molecular size and 
biological activity. 
Ion-Exchange Chromatography.  To further resolve any differences in the biochemical 
properties of pools I and II eluted from ACA 54, these biologically active components 
were analyzed by ion-exchange chromatography. The fractions collected were ana- 
lyzed at a  1:10 dilution for their helper activity with BALB/e nude spleen cells and 
for their TCGF-Iike activity at a  1:5 dilution with CTLL cells. 
It is evident from Fig.  3A that pool I  eluted from DEAE-Sephacel with a  major 
peak between 0.05 M  and 0.1  M  NaCI-Hepes, pH  7.2,  and a  minor peak between 
0.15 M  and 0.2 M  NaCI-Hepes, pH  7.2.  A  similar elution profile was obtained for DELOVITCH  ET  AL.  113 
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FIo.  2.  Assay of AEF activity after gel filtration on ACA 54. (A)  Column fractions were assayed 
for their capacity to promote at a  1  : 10 dilution a  primary in vitro anti-SRBC direct PFC response 
of BALB/c nude spleen cells (A) or to stimulate at a  1:5 dilution CTLL cell growth (0). PFC results 
are expressed in terms of the fraction of responding microcuhures in the 120 cultures tested for each 
column fraction  (11).  Results of cell  growth are expressed as  [aH]thymidine counts per  minute 
incorporated  into trichloroacetic  acid-precipitable  DNA. The molecular weight  markers used to 
calibrate the column were human serum albumin (67,000), ovalbumin (43,000), TCGF (~30,000), 
and cytochrome c (12,500). (B) Column fractions were assayed at a  1:10 dilution for their ability to 
stimulate an anti-SRBC response of either B I0.S (0) or B 10.A (A) T  cell-depleted spleen cells. In 
(A) and (B) above, two distinct components, pools I and II, were identified. 
pool II (Fig. 3 B). The contamination of pool I with pool II in Fig. 3 A and vice-versa 
in Fig. 3 B presumably arises from the manner in which pools I and II were originally 
selected (Fig. 2). Interestingly, AEF helper activity resided in fractions eluting both at 
low (0.05-0.1  M)  and high (0.15-0.2  M)  NaCI concentrations, whereas TCGF-like 
activity was present only in those fractions eluted at the higher NaCI concentration 
(Fig. 3 B). Thus pool I  activity may be fractionated between 0.05 and 0.1  M  NaCI 
and pool II activity may be fractionated between 0.15 and 0.2 M  NaCI. This further 
demonstrates  that  the  biologically active  pools  I  and  II  consist  of biochemically 
different  molecules.  Because  pool  I  lacks  TCGF-Iike  activity  but  possesses  H-2- 
restricted helper activity, it  was of interest to  further characterize the major peak 
eluted from DEAE-Sephacel at 0.05-0.1  M  NaCI, which was designated as pool III. 114  TWO COMPONENTS  OF ALLOGENEIC  EFFECT  FACTOR 
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FIo. 3.  Assay  of AEF activity after ion-exchange chromatography on  DEAE-Sephacel. Active 
AEF components obtained from ACA 54 pool I (A) and ACA 54 pool II (B) were fractionated on 
DEAE-Sephaeel and assayed either for their helper activity with BALB/c nude spleen cells (&) or 
their ability to stimulate CTLL cell growth (0). The concentration gradient of 0.04-0.4 M NaCI- 
Hepes, pH 7.2, is indicated (---). Fractions eluted between 0.05 and 0.1 M NaC1 were designated as 
pool III. 
IEF.  AEF pool III collected from the DEAE-Sephacel eluates shown in Fig. 3 was 
separated  by IEF using a  pH gradient  of 3-10.  Two major peaks of helper activity 
(assayed at a  1:3 dilution) for B 10.A T  cell-depleted spleen cells were obtained by IEF 
on  a  horizontal  flat-bed  of Sephadex  G-75  (Fig.  4A).  The  isoelectric  point  (pI)  of 
peak I was 5.8 and of peak II was 6.2. It should be noted that a broad peak of activity 
with  a  pI  in  the  5.5-6.5  range  was  sometimes  observed  (J.  Watson.  Unpublished 
observation.).  It, therefore,  remains  uncertain  whether  peaks  I  and  II represent  two 
distinct  molecules of similar molecular size and different molecular charge. 
When pool III of the DEAE-Sephacel column was separated by IEF on a preparative 
vertical column stabilized with a  gradient of 0-60% glycerol, one predominant  peak 
with a pI in the range of 5.5-6.0 was observed (Fig. 4 B). The latter peak preferentially 
helped  an  anti-SRBC  direct  PFC  response of T  cell-depleted  spleen  cells of the A/ 
WySn stimulator haplotype and not of the A.SW responder haplotype. Thus, the H- 
2-restricted helper activity of AEF was maintained throughout the several biochemical 
methods of resolution used and seems to reside with a  major component, component 
I, of pI 5.5-6.0. 
Gel  Electrophoresis.  To  further  analyze  whether  the  H-2-restricted  AEF  helper DELOVITCH ET AL.  115 
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or A.SW (0) and A/WySn (C)) T  cell-depleted spleen cells (B). 
activity of pI 5.5-6.0 is attributable to one or perhaps more than one component, the 
IEF fractions containing helper activity were characterized by gel electrophoresis. 
Fractions  17 and  19 of AEF component I shown in Fig. 4A were each dialyzed to 
remove Ampholines,  concentrated,  and  labeled  with  ]2sI using  the  Bohon-Hunter 
reagent. They were then fractionated on Sephadex G-25 to remove free lzsI, dialyzed, 
concentrated, and applied to a lentil lectin affinity column; the unbound and bound 
fractions were lyophilized, dissolved, and analyzed under reducing conditions by 1-D 
10% SDS-PAGE. The gel fluorogram presented in Fig. 5 demonstrates that the lentil 
lectin-unbound material of fractions 17 (track A) and  19 (track B) consists of a major 
band in the 68,000-mol wt  (Fig. 5, 68 K) region. This band is absent from the lentil 
lectin-bound  material of these  fractions  (Fig.  5,  tracks C  and  D).  Another band  at 
-10,000-15,000  tool  wt  which  comigrated with  the  Coomassie blue  dye front  was 
present in both of the unbound and bound fractions (Fig. 5, tracks A-D). These data 
suggest  that  the 68,000-mol  wt  component  does not  possess mannose residues  and, 
therefore, may not be a glycoprotein. The glycoprotein nature of the 10,000-  to 15,000- 116  TWO  COMPONENTS  OF  ALLOGENEIC  EFFECT  FACTOR 
Fl+.  5.  I-D gel fluorogram of 12Sl-labeled AEF component I  after IEF and  lentil  lectin affinity 
chromatography.  Flat-bed  IEF  fractions  17  (tracks A  and C)  and  19  (tracks  B  and  D)  of AEF 
component I (Fig. 4A) were radioiodinated, separated on a lentil lectin column into their unbound 
(tracks A and B) and bound (tracks C  and D) components, respectively, and then analyzed under 
reducing conditions by  1-D  10% SDS-PAGE. The position of migration of the molecular weight 
markers,  bovine serum  albumin  (68,000),  Ig  heavy chain  (55,000),  ovalbumin  (43,000),  porcine 
lactate dehydrogenase (36,000),  and Ig L+cbain (25,000)  are indicated by arrows. DELOVITCH ET AL.  1 17 
mol wt component remains uncertain, as it appeared in both of the lectin-bound and 
-unbound fractions. It is possible, however, that these lectin fractions contain proteins 
of similar molecular size but that are either glycoprotein or nonglycoprotein in nature, 
respectively. 
To determine whether the 68,000- and  10,000-  to  15,000-mol wt components can 
be  found  in  associated  form  in  a  larger  molecular  weight  complex,  125I-labeled 
fractions 17 and  19 of Fig. 4A and pooled fractions 17-19 of Fig. 4B were subjected 
to electrophoresis under nonreducing conditions. For comparison, the samples were 
also  run  under  reducing  conditions  on  the  same  1-D  slab  gel.  Samples  were  not 
subjected to lentil lectin chromatography before electrophoresis. The results shown in 
Fig. 6 reveal that identical gel patterns were obtained when fractions 17, 19, and  17- 
19 were analyzed under reducing (tracks A, C, and E, respectively) and nonreducing 
(tracks B, D, and F, respectively) conditions. Two major bands were observed in the 
68,000- and  10,000-  to  15,000-tool wt regions. The bands were quite broad because 
the gel was overloaded with the samples to identify any possible contaminating minor 
components.  Because no proteins ~68,000  mol wt were seen, it is unlikely that  the 
68,000-  and  10,000-  to  15,000-mol  wt  components  are  covalently  associated.  A 
noncovalent association between these components may not be ruled out, however, as 
they were run in the presence of SDS. 
To examine the possible subunit structure of the two AEF components, 125I-labeled 
fractions  17,  19,  and  17-19  were  subjected  to  electrophoresis  under  dissociating 
conditions on a  1-D acid-urea  10% polyacrylamide slab  gel in the absence of SDS 
(20). Only the 68,000- and  10,000- to 15,000-mol wt components appeared on this gel 
(T. Deiovitch. Unpublished observations.). Thus, these AEF components do not seem 
to be composed of noncovalently associated subunits. 
The molecular heterogeneity of these components was further assessed by 2-D gel 
electrophoresis. The fluorogram of 125I-labeled fraction 17-19 (Fig. 4 B) shown in Fig. 
7 reveals a major spot (enclosed area) having a mol wt of ~68,000 and a pI of ~5.8. 
This pI value is in close agreement with that previously estimated for this component 
by preparative IEF (Fig. 4). Moreover, the gel pattern indicates that this component 
is presumably homogeneous because one, and only one, spot was evident in this region 
of the gel. In contrast, the radioactivity that appeared in the 10,000- to 15,000-mol wt 
region at the dye front of the gel was not confined to a single discrete spot but was 
spread across the entire pH gradient. It is therefore possible that the 10,000- to 15,000- 
mol wt component identified above is not a  single protein with biological activity, 
but  rather that  this mol wt region contains a  series of products of similar size that 
result from the degradation of either the 68,000-mol wt component or of a  protein 
somewhat larger in mol wt than 68,000. Alternatively, the radioactivity in the 10,000- 
to  15,000-mol  wt  regions of the  gels  shown  in  Figs.  5-7  may derive in  part  from 
residual non-protein-bound, free ~25I in the samples. 
Taken together, the gel analyses presented above suggest  that  the H-2-restricted 
helper activity of AEF is a property of a single, non-glycoprotein having a mol wt of 
-68,000 and a pI of ~5.8. 
Serological Characterization.  Because the 68,000-mol wt component of AEF appears 
to be a single, responder T cell-derived product that recognizes Ia antigens determined 
by the I-A  subregion  of the  stimulator  haplotype, it  was  considered  important  to 
serologically identify the antigenic determinants on this molecule. 118  TWO  COMPONENTS  OF  ALLOGENEIC  EFFECT  FACTOR 
Fie:.  6.  I-D gel fluorogram of 12'~I-labeled AEF component I after IEF.  Flat-bed IEF fractions  17 
(tracks A  and  B)  and  19  (tracks C  and  D)  of Fig.  4A and  vertical-column  IEF  fractions  17-19 
(tracks E and F) of Fig. 4 B were radioiodinated and analyzed by I-D  10% SDS-PAGE under either 
reducing (tracks A, C, and  E)  or nonreducing (tracks B,  D, and  F) conditions. Molecular weight 
markers are as in Fig. 5. DELOVITCH  ET  AL.  119 
Fro.  7.  2-D  gel  fluorogram of I~I-labeled AEF component I  after IEF.  mI-labeled samples of 
vertical-column IEF fractions 17-19 (Fig. 4B) were separated by IEF in the first dimension (left to 
right) and by 10% SDS-PAGE in the second dimension (top to bottom). The basic end (pH 7.5)  is 
at the left and the acidic end pH (4.5)  at the right. Molecular weight markers are as in Fig. 5. The 
radioactive spot in the 68,000-mol wt region at pl 5.8 is enclosed. 120  TWO  COMPONENTS  OF  ALLOGENEIC  EFFECT  FACTOR 
IEF fractions  17 and  19  (see  Fig.  4A)  were pooled, radioiodinated, and aliquots 
containing -5,000-6,000 cpm were immunoprecipitated with various antisera over- 
night. They were then treated for 30 rain with SaCI and the pellets were counted. A 
similar method of serologic analysis was recently used to characterize hapten-specific 
T  cell hybrid products (14). The results presented in Table II indicate that each of 
the antisera used yielded a  negative reaction with the purified, 68,000-mol wt H-2- 
restricted component of AEF. Thus, within the limits of sensitivity of this radioim- 
munoassay, which is considered to be more direct and perhaps more sensitive than 
testing for biological activity of factors after immunoadsorption (see Fig.  1 B), it can 
be concluded that the 68,000-mol wt AEF component does not bear any Ia determi- 
nants of either the stimulator or responder haplotype, does not carry Ig isotypic H- 
chain  and  L-chain determinants or Ig idiotypic determinants,  and  is  unrelated  to 
BSA and gpT0. 
Discussion 
To further probe the molecular basis for the H-2 restriction of  allogeneic lymphocyte 
interaction, a biological and biochemical analysis of an AEF produced across an H-2 
difference was carried out. The results presented demonstrate that  AEF consists of 
two distinct components that possess different biochemical and biological properties 
(see Table III). 
One component, component I, chromatographs in  the 50,000-  to  70,000-mol wt 
range  by  gel  filtration  on  ACA  54  under  nondissociating  conditions,  elutes  from 
DEAE-Sephacel  between  0.05  and  0.1  M  NaCl,  has  a  pI  of ~5.8,  and  is  not  a 
glycoprotein as  based  on  its  inability  to  bind  to  lentil  lectin.  Gel electrophoretic 
analyses indicated that component I is comprised of a single, homogeneous protein of 
~68,000 mol wt. It is rather unlikely that this protein is either mouse serum albumin 
TABLE II 
Serological Characterization of AEF Component I 
Antiserum  cpm precipitated* 
A.TH anti-A.TL (anti-I  k)  85 
(A.TH ×  B10.H'I~F, anti-A.TL (anti-l-A k)  46 
(B 10 ×  HTI)F, anti-B10.A(5R)  (anti-/-E  k)  56 
A303 (anti-Aek:Eak):~  42 
A.TL anti-A.TH (anti-l')  61 
Normal mouse serum  52 
Rabbit anti-mouse Vn  79 
Rabbit anti-mouse VL  85 
Rabbit anti-mouse Fv  65 
Rabbit anti-CRI  90 
Rabbit anti-Thy- 1  59 
Rabbit anti-BSA  95 
Rabbit anti-mouse Ig  83 
Normal rabbit Ig  75 
Goat anti-gp 70  70 
None  20 
* Each reaction included 5,000-6,000  cpm of l~I-labeled AEF component I, 25 #! of antiserum, and  100 
#1 of SaCI. The arithmetic mean of cpm precipitated in duplicate samples is shown. 
:~ Approximately 30 #g of purified A303 IgG~ monoclonal anti-Aek:Ea  k (12) was used. DELOVITCH ET AL. 
TABLE III 
Biochemical, Serological, and Biological Properties of AEF 
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Property  Component I  Component II 
Biochemical 
Molecular weight (ACA 54)  50,000-70,000  30,000-35,000 
Molecular weight (SDS-PAGE)  68,000  ND* 
Salt elution from DEAE-Sephacel  0.05-0.1 M  0.15-0.2 M 
pI  5.8  4.3, 4.9 
Lentil lectin affinity  -  - 
Serological 
Ia 
Ig (isotypic  and idiotypic) 
B  m 
Biological 
Helper activity 
1-1-2 restricted  +  - 
H-2 nonrestricted  -  + 
Stimulation of CTLL growth  -  + 
Stimulation of thymocyte mitogenesis  -  + 
Generation of cytotoxic T  cells  -  + 
* ND, not done. 
(mol  wt  68,000)  or  gp  70,  the  major  envelope glycoprotein  (mol  wt  =70,000)  of 
murine leukemia RNA viruses. Serum albumins from a variety of species have a pI of 
4.7 (21), and gp 70 is a  glycoprotein that has extensive pI microheterogeneity in the 
pH range of 4-6 (22). The latter two proteins, therefore, differ from the AEF 68,000- 
mol wt component in their net charge. In addition, the 68,000-mol wt component of 
AEF is not immunoprecipitable by either rabbit anti-BSA or goat anti-Scripps virus 
gp 70 antisera (Table II). A band of 10,000-15,000 mol wt was also evident in the gel 
electrophoretograms of component I; however, as a  result of its considerable charge 
heterogeneity on a 2-D gel, we tentatively concluded that this region of the gel consists 
primarily of either degradation products or free lz~I and not a discrete product (s) with 
biological activity. The latter conclusion is compatible with the observation that no 
AEF helper activity was found in this molecular size region upon  fractionation on 
ACA 54. Component I possesses  helper activity for H-2 a nude spleen cells, for T  cell- 
depleted spleen cells of the stimulator (H-2~), but not the responder (H-2~), haplotype, 
and  for T  cell-depleted spleen cells of haplotypes that  share only an/-A-subregion 
identity with  the  stimulator  haplotype.  Thus,  the  helper  activity of component  I 
seems to be H-2 restricted. 
Component  II  has  a  tool  wt  of-30,000-35,000,  elutes  from  DEAE-Sephacel 
between 0.15 and 0.2 M  NaCI, and does not bind to lentil lectin (data not shown). It 
elicits  a  primary  anti-SRBC  response of nude  spleen  cells  and  of T  cell-depleted 
spleens of both the responder and stimulator haplotypes. Moreover, it also stimulates 
(a) the growth of a CTLL cell line in vitro, (b) thymocyte mitogenesis in the presence 
of nonmitogenic doses of Con A, and (c) the generation of cytotoxic T  cells in either 
thymocyte or nude spleen cell cultures. The latter three biological activities are not 
manifested by component I. Furthermore, whereas the helper activity of component 
I is H-2 restricted, the helper activity of component II is not H-2 restricted. It is clear, 122  TWO COMPONENTS OF ALLOGENEIC EFFECT FACTOR 
therefore, that  AEF components I  and  II differ markedly in  their biochemical and 
biological properties. 
The properties described here for component II are identical to these previously 
reported for a class of lymphokines derived from culture supernates of Con A-activated 
mouse  spleen  cells  and  known  as  TCGF  (11),  or  otherwise  designated  as  either 
costimulator or interleukin-2 (23,  24).  TCGF has pI of 4.3 and 4.9 (11) and does not 
bear Ia antigens (23). These findings indicate that TCGF can also be found in MLR 
culture supernates and appears to be a  major active component of AEF. It is likely 
that  this component is a  T  cell product because a  factor with similar activity has 
recently  been  detected  in  the  supernatant  fluids  of a  Con  A-stimulated  T  cell 
hybridoma (25)  and  TCGF was  recently shown  to be produced by/-A-negative T 
lymphocytes (26). 
Con A-activated spleen cell supernates also contain another lymphokine of 30,000 
mol wt that has a pI of 3-4, activates a nongenetically restricted anti-SRBC response 
of T  cell-depleted spleen cells, and  does not  possess  any of the T  cell stimulatory 
activities  common  to  TCGF  and  AEF  component  II  (11).  This  lymphokine  is 
commonly termed T  cell-replacing factor (TRF)  (27).  It  is not yet known whether 
AEF contains TRF-like activity. If this is the case, TRF would be a  constituent of 
AEF component II and could be separated from the TCGF-Iike activity in AEF by 
isoelectric focusing. 
A  comparison may be made of the biochemical and  biological properties of the 
AEF described above with those of another AEF, which for clarity and simplicity will 
be termed AEF'. Whereas AEF' was shown by Armerding et al.  (28)  to consist of a 
40,000- to 65,000-mol wt component when fractionated under nondissociating con- 
ditions, the AEF characterized in this study yielded 50,000- to 70,000- and 30,000- to 
35,000-mol wt peaks of activity when separated under similar conditions. These AEF 
components did not bind to lentin lectin, whereas AEF' did bind to lentil lectin. The 
DEAE-Sephacel elution profiles of both AEF'  and  AEF displayed peaks of helper 
activity at  0.07  M  NaCI  and  0.14-0.2  M  NaCI.  Chromatography of AEF'  under 
dissociating conditions demonstrated that it consists of 40,000-mol wt and 12,000-tool 
wt components, respectively. Electrophoresis patterns of the AEF 50,000- to 70,000- 
mol  wt  peak  under  either  nonreducing,  reducing,  or  dissociating  conditions  each 
revealed a major band at 68,000 mol wt and a minor band at  10,000-15,000 tool wt. 
The relationship of the latter low molecular weight AEF component to the  12,000 
dalton AEF' component is unknown, because no biological activity was ever found to 
be  associated  with  a  10,000-  to  15,000-mol  wt  component  of AEF.  Similarly,  no 
functional relationship is apparent  between the 40,000- to 65,000-mol wt  nondisso- 
ciated form of AEF' and the 68,000-mol wt component I of AEF. Both the nondisso- 
ciated form of AEF' and  its two subunits,  which act synergistically, provide helper 
activity  for  T  cell-depleted  spleen  cells  of the  responder  haplotype  (activity  for 
stimulator haplotype was not tested). The helper activity of AEF component I was H- 
2 restricted for cells of the stimulator haplotype. Because the 30,000- to 35,000-mol wt 
component II of AEF is not genetically restricted, it may be functionally related to 
the 40,000-tool wt  subunit  of AEF'.  Compatible with  this suggestion  is  the  recent 
observation that AEF' can autonomously induce a primary CTL response in vitro in 
the absence of stimulating target cells during the sensitization phase.(29). This AEF' 
activity presumably is mediated by its TCGF-Iike activity which probably resides in DELOVITCH ET AL.  123 
its 40,000-mol wt component. As shown above, the 30,000- to 35,000-mol wt compo- 
nent  II of AEF displays TCGF-like activity. Hence, although AEF' and AEF have 
some biochemical and  biological properties in  common, they also  differ in  certain 
other properties. 
As  (a)  helper T  cells interact in an H-2-restricted manner with both antigen and 
self Ia determinants on macrophages and B cells (reviewed in 1, 2, and 9) and (b) AEF 
component I is H-2 restricted in its helper activity, the immunological significance of 
this 68,000-mol wt protein warrants further discussion. The biological importance of 
the TCGF-like AEF component II has already been discussed elsewhere (11, 30). 
AEF  component  I  is  most  likely a  product  of an  alloactivated  MLR  responder 
helper T  cell. Support for this cellular origin of component I derives from two main 
findings. First, ~90-95% of the alloactivated MLR responder cell population used to 
prepare AEF was serologically detected to be GVHR donor T  cells. It is known that 
GVHR donor T  cell blasts passively acquire host  cell-derived H-2 and  Ia antigens 
onto their surface  (10), a  similar  intercellular exchange of Ia antigens occurs from 
stimulator cells to responder T  cells during an MLR (31). In addition, the Ly antigen 
phenotype of these GVHR- and MLR-activated T  blasts is Lyt-1+,2  -  (10, 31), which 
is identical to the Ly antigen phenotype of antigen-specific helper T  cells (32). These 
data previously prompted us to propose that  this cellular transfer of Ia antigens  is 
responsible  in  part  for the H-2 restricted interactions of antigen-  and  alloantigen- 
specific helper T  cells (10). Note that TCGF also requires the presence of Lyt-l+,2  -  T 
cells for its production (26), and hence AEF components I and II may be products of 
the same T  cell subpopulation.  Second, component  I  possesses  helper activity and 
seems to recognize Ia antigens of the GVHR host and MLR stimulator haplotype. It 
is, therefore, conceivable that component I is a GVHR donor and MLR responder T 
cell surface membrane protein that binds to host and stimulator Ia antigens, and is 
present in AEF because it is either shed or secreted by the activated MLR responder 
T  cells.  If this is indeed the case, then this 68,000-mol wt component of AEF might be 
classified as a T  cell alloantigen receptor. 
AEF  is  commonly  regarded  as  an  antigen-nonspecific  helper  factor.  However, 
because  AEF  component  I  exhibits  alloantigen  specificity,  AEF  should  now  be 
considered to be an alloantigen-specific helper factor. 9 out of 10 AEF examined thus 
far elicit H-2-restricted helper activity (Table I). It is probable that these AEF each 
consist of a structurally distinct 68,000-mo1 wt component that has binding specificity 
for different Ia determinants. As a corollary, this might infer the existence of a large 
repertoire of polymorphic T cell receptors for H-2-1inked alloantigens. The observation 
that  the helper activity of AEF component I  is about  twofold greater than that  of 
component II  (Fig. 2)  might explain why most AEF preparations when tested at an 
appropriate dilution manifest H-2-restricted help. We suggest that the H-2-restricted 
or  non-H-2-restricted  activity of a  particular  AEF  is  dependent  upon  its  relative 
amounts of component I and II identified herein. 
Based on immunoadsorption studies, we have previously reported that various AEF 
are Ia-positive helper factors (4-7, 9). These Ia antigens were shown to be stimulator 
B cell and/or macrophage derived. In the present study, it is important to note that 
although a similar immunoadsorption experiment indicates that AEF bears stimulator 
haplotype derived Ia antigens (Fig.  1), a more direct and sensitive serological assay of 
AEF component I suggests that this H-2-restricted component is Ia-negative (Table 124  TWO COMPONENTS OF ALLOGENEIC EFFECT FACTOR 
II).  Furthermore,  spots  corresponding  to  Ia  antigens  are  absent  from  the  2-D  gel 
fluorogram  of component  I  (Fig.  7).  It  is  possible  that  stimulator  cell-derived  Ia 
antigens  are  active  components  of AEF  and  can  perhaps  bind  noncovalently  to 
component I of AEF when AEF is in an unfractionated form. A biochemical resolution 
of AEF into its various components may, as a result of extensive manipulation, cause 
the dissociation of Ia antigens from the 68,000-mol wt component of AEF. Neverthe- 
less,  because various anti-Ia sera do not  bind  to this 68,000  component, this result 
would tend to negate the possibility that such antisera contain anti-idiotype antibodies 
that bind to the anti-self Ia idiotype of T  cell-derived factors (33). 
Although  we have proposed that AEF component  I  recognizes Ia antigens deter- 
mined  by the  I-A k subregion,  the reason  for its helper activity for BALB/c  (H-2 a) 
nude spleen cells was unclear. The model of two-gene complementation for Ia antigens 
(34)  might  explain  this  result.  The H-2 k  and  H-2 a  haplotypes express  Ia antigens 
composed of an a-chain subunit (E~) controlled by a gene in I-E that is noncovalently 
associated with a fl-chain subunit (A~) controlled by a gene in I-A. Ae  k and Ae  a possess 
-40-50% structural homology, whereas E,  k and E~  a share -90% structural homology 
(35).  In certain cases, helper T  cells recognize an antigen in association with an Ae:Eo 
complex on the surface of an antigen-presenting macrophage (36).  In addition, some 
clones of alloreactive T  cells appear to recognize, and are stimulated by, the surface 
form of the A~ chain  (37).  Thus, the 68,000-mol wt component of AEF may have a 
binding capacity for membrane-bound Ae  k and Ae  a chains of macrophages and/or B 
cells in nude spleen and T  cell-depleted spleen cell populations. More significantly, if 
this type of interaction can be shown to occur preferentially for macrophage-derived 
Ia antigens,  this would  provide strong support  for the claim that  H-2 restriction  of 
lymphocyte interaction occurs primarily between T  cells and accessory cells (macro- 
phages) and not between T  cells and B cells (38). 
Our  previous  observations  that  Ia  antigens  determined  by  only  the  stimulator 
haplotype and not the responder haplotype (5-8) led us to postulate that AEF is a B 
cell and/or  macrophage product.  The data presented  herein,  however, suggest  that 
the  H-2-restricted  activity of AEF  is  conferred  not  by Ia antigens  themselves, but 
rather by an Ia-negative, and possibly Vn- and idiotype-negative, alloactivated T cell- 
derived, 68,000-mol wt protein that can recognize and bind to Ia antigens on B cells 
and/or  macrophages.  This  AEF  component  may  in  fact  bear  VH  and  idiotypic 
determinants that differ from those detected by the sera used. It seems that a ligand: 
receptor interaction, which is Ia:anti-Ia in nature, is mediated by AEF component I. 
We therefore now reinterpret our original observations to suggest that whereas AEF 
Ia antigens may be products of B cells and macrophages, the Ia-negative,/-A-restricted 
component of the AEF analyzed here is an alloactivated T  cell product. 
During the last few years, a number of soluble T  cell-derived helper and suppressor 
factors have been described. Although  their active components were not  purified to 
apparent  homogeneity,  their  biological  activity  was  ascribed  to  molecules  in  the 
40,000- to 70,000-mol wt range. More recently, with the availability of the hybridoma 
and T  cell cloning technologies, products of both T  cell hybrids formed by the fusion 
of a thymoma cell line with antigen-specific suppressor T  cells (14)  and of nontrans- 
formed, antigen-specific suppressor T  cell clones (39)  have been characterized.  Some 
of these molecules have been shown to have a  mol wt of either 62,000  (14)  or 68,000 
(39)  and  to express  (14,  40)  or not  express  (39)  Ia determinants.  Another  antigen- DELOVITCH ET AL.  125 
specific suppressor factor derived from uncloned T  cells, when purified, was shown to 
have a  mol wt of 68,000  and to be Ia negative  (41).  Although  none of these T  cell 
products bear any known Ig isotypic H  or L  chain determinants, one of them seems 
to carry cross-reactive idiotypic determinants  (14).  The AEF component  I  purified 
and characterized  here is similar in size (68,000  mol wt)  to the above-mentioned T 
cell products,  does not possess Ia determinants,  and bears neither Vn, CH, L-chain, 
nor  idiotypic  determinants.  This  AEF  component  bears  some  resemblance  to  a 
previously  identified  70,000-mol  wt,  Ia-negative,  idiotype-positive  constituent  of 
alloactivated T  cells (42).  More extensive biochemical and biological analyses of the 
above-mentioned, as well as other, T  cell-derived products should ultimately resolve 
the  molecular  nature  of antigen-specific  and  alloantigen-specific  T  cell  receptors. 
They may even provide an answer the problem of whether dual recognition by T  cells 
is mediated by either two receptors--one receptor for foreign antigens and a  second 
receptor for H-2 antigens--or a single receptor for these two groups of antigens. 
Summary 
An allogeneic effect factor (AEF) derived from mixed lymphocyte reaction (MLR) 
cultures of alloactivated A.SW (H-2 ~) responder T  cells and irradiated A/WySn (H- 
2 a) stimulator spleen cells helps an in vitro primary anti-erythrocyte plaque-forming 
cell  PFC response of BALB/c nude spleen cells and also A/WySn but  not A.SW T 
cell-depleted spleen cells. AEF activity is adsorbed by anti-I  k and anti-I-A k but  not 
by anti-I-J  k, anti-I-EC k, and anti-/8. Gel filtration of ACA 54 resolves AEF into two 
main components that which appear in the 50,000- to 70,000-mol wt  (component I) 
and 30,000- to 35,000-mol wt (component II) regions, respectively. Component I has 
a  mol wt  of 68,000,  elutes  from DEAE-Sephacel  at  0.05-0.1  M  NaC1,  and  has  an 
isoelectric point  (pI) of 5.8. It helps A/WySn but not A.SW B cells and, therefore, is 
H-2 restricted.  Component II is not H-2 restricted, because it helps both A.SW and 
A/WySn B cells. It also stimulates (a) the growth of a long-term cytotoxic cell line in 
vitro,  (b)  Con A-induced  thymocyte mitogenesis, and  (c)  the generation of cytotoxic 
T  cells. The latter three properties of component II are not shared by component I. 
In addition, component II elutes from DEAE-Sephacel at 0.15-0.2  M  NaCI and has 
a  pI of 4.3 and 4.9.  Ia determinants and Ig Vm Cn, L-chain, and idiotypic determi- 
nants  are  not  present  on  either  component  I  or component  II.  The  properties  of 
component  II are  identical  to  that  of a  T  cell  growth  factor produced  by Con  A- 
stimulated  spleen cells.  It is suggested that  the H-2-restricted component  I  of AEF 
might be an MLR-activated responder T  cell-derived Ia alloantigen receptor. 
We thank Ms. Donna Crawford for her cheerful secretarial assistance. 
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